IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $886,000 | -14.6% | 92,500 | -1.6% | 0.36% | -11.9% |
| Q2 2022 | $1,038,000 | -34.0% | 94,000 | -0.5% | 0.41% | -24.2% |
| Q1 2022 | $1,573,000 | -12.8% | 94,500 | 0.0% | 0.54% | +1.3% |
| Q4 2021 | $1,804,000 | -22.6% | 94,500 | 0.0% | 0.54% | -23.4% |
| Q3 2021 | $2,330,000 | -8.1% | 94,500 | -3.0% | 0.70% | -18.8% |
| Q2 2021 | $2,535,000 | +10.9% | 97,444 | +35.0% | 0.86% | +32.9% |
| Q1 2021 | $2,285,000 | -28.8% | 72,168 | +4.3% | 0.65% | -27.1% |
| Q4 2020 | $3,209,000 | +729.2% | 69,168 | +488.7% | 0.89% | +616.1% |
| Q3 2020 | $387,000 | +779.5% | 11,750 | +135.0% | 0.12% | +726.7% |
| Q4 2018 | $44,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |